Last Updated: Jul 28, 2020
The Drug Enforcement Administration (DEA) has issued a final rule adjusting its fee schedule for registration and re-registration. This final rule raises registration and re-registration fees for all DEA registrants. Additionally, this final rule also lists limited circumstances by which application fees may be refunded.
Click here to access the full final rule in the Federal Register.
For practitioners, the fee for DEA registration will increase from $731 to $888.
The final rule takes effect October 1, 2020. The new fee schedule will be implemented for all initial applications submitted on or after October 1st, and for all renewal applications submitted on or after October 1. DEA registrations are renewed every three years at the same price.
The DEA cites the need to raise registration fees as necessary to recover the costs of its Diversion Control Program (DCP) relating to the registration and control of the manufacture, distribution, dispensing, importation and exportation of controlled substances and list I chemicals as mandated by the Controlled Substances Act (CSA). Without these increases, the DEA states that it would be unable to continue its current operations and to comply with the statutory mandate to recover all costs associated with managing the DCP.
DEA application fees are generally not refundable. However, the final rule lists limited circumstances under which, at the discretion of the DEA Administrator, refunds of fees may be issued. These circumstances include:
- Applicant error (such as duplicate payments, payment for incorrect business activities, or payments made by persons who are exempt from application or renewal fees);
- DEA error; and
- Death of a registrant within the first year of the three-year registration cycle.
Access PAMED’s “Answers to Physician FAQs on DEA Registration, Renewal, and Reporting” here.
For additional information regarding DEA registration, please visit the DEA Diversion Control Division website here.